CMAX

CareMax, Inc. [CMAX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CMAX Stock Summary

Top 10 Correlated ETFs

CMAX


Top 10 Correlated Stocks

CMAX


In the News

06:10 29 Mar 2024 CMAX

New Strong Sell Stocks for March 28th

ASLE, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2023.

07:31 29 Mar 2024 CMAX

New Strong Sell Stocks for March 20th

CMAX, LNZA and HSON have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2024.

07:42 29 Mar 2024 CMAX

CareMax, Inc. (CMAX) Q3 2023 Earnings Call Transcript

CareMax, Inc. (NASDAQ:CMAX ) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Roger Ou - Senior Vice President of Investor Relations Carlos de Solo - Co-Founder, President, CEO & Director Kevin Wirges - EVP, CFO & Treasurer Conference Call Participants Eduardo Ron - Truist Securities Jessica Tassan - Piper Sandler Jack Slevin - Jefferies Operator Good morning, and welcome to the CareMax, Inc. Third Quarter 2023 Financial Results and Conference Call. [Operator Instructions] I would now like to turn today's call over to Roger Ou, Senior Vice President of Investor Relations.

06:55 29 Mar 2024 CMAX

CareMax Schedules Third Quarter 2023 Earnings Conference Call

MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants.

04:46 29 Mar 2024 CMAX

CareMax Strategy Faces High Initial MER Costs

CareMax, Inc. provides value-based care services to seniors in the United States. The firm's strategy is to elect into full-risk MSO Medicare plans even though it may have higher initial expense ratios. With tight liquidity, cash burn and heavy upfront MER costs, I'm Neutral [Hold] on CareMax, Inc. shares for now.

06:55 29 Mar 2024 CMAX

CareMax to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer, Carlos de Solo, and Chief Financial Officer, Kevin Wirges, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023, at 7:30 am Eastern Time. A live webcast and replay of the event will be available on CareMax's investor relations webs.

09:58 29 Mar 2024 CMAX

CareMax, Inc. (CMAX) Reports Q2 Loss, Tops Revenue Estimates

CareMax, Inc. (CMAX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.11 per share a year ago.

06:55 29 Mar 2024 CMAX

CareMax Schedules Second Quarter 2023 Earnings Conference Call

MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that it will release its financial results for the second quarter 2023 before the opening of the financial markets on Wednesday, August 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for.

12:50 29 Mar 2024 CMAX

CareMax: Reiterate Buy On Potential Future Growth

CareMax offers a unique healthcare delivery model for managing chronic diseases and value-based care for the elderly population, with potential for significant growth in the expanding Medicare market. CMAX's integrated approach, including its Clinic strategy and wellness center, sets it apart from competitors and improves patient outcomes while reducing healthcare costs. Despite execution risks in venturing into new markets, CMAX's established presence in South Florida and the integration with Steward Health Care System offer a strong foundation for future growth and improved financial performance.

06:55 29 Mar 2024 CMAX

CareMax to Present at the Jefferies Healthcare Conference

MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer, Carlos de Solo, and Chief Financial Officer, Kevin Wirges, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023, at 11:00 am Eastern Time. A live webcast and replay of the event will be available on CareMax's investor relations website at ir.caremax.com. About.

CMAX Financial details

Company Rating
Neutral
Market Cap
22.32M
Income
-683.35M
Revenue
751.1M
Book val./share
16.43
Cash/share
17.52
Dividend
-
Dividend %
-
Employees
1.45K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-0.2
Forward P/E
-0.21
PEG
-0
P/S
0.05
P/B
0.08
P/C
0.28
P/FCF
-0.4
Quick Ratio
1.76
Current Ratio
1.8
Debt / Equity
6.43
LT Debt / Equity
0.35
-
-
EPS (TTM)
-126.48
EPS next Y
-23.16
EPS next Q
-7.57
EPS this Y
43545.24%
EPS next Y
-81.69%
EPS next 5Y
-98.11%
EPS last 5Y
-
Revenue last 5Y
52.66%
Revenue Q/Q
-24.78%
EPS Q/Q
13435.87%
-
-
-
-
SMA20
-30.64%
SMA50
-53.33%
SMA100
-91.93%
Inst Own
49.52%
Inst Trans
0.75%
ROA
-20%
ROE
-36%
ROC
-0.14%
Gross Margin
12%
Oper. Margin
-18%
Profit Margin
-27%
Payout
-
Shs Outstand
3.8M
Shs Float
2.33M
-
-
-
-
Target Price
6
52W Range
3.72-126.0
52W High
-96.17%
52W Low
+60.67%
RSI
42.45
Rel Volume
0.46
Avg Volume
74.58K
Volume
33.94K
Perf Week
-1.63%
Perf Month
3.21%
Perf Quarter
-93.47%
Perf Half Y
-92.46%
-
-
-
-
Beta
0.866
-
-
Volatility
0.74%, 2.73%
Prev Close
9.55%
Price
4.82
Change
16.71%

CMAX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
01.295.767.01201.49
Net income per share
00.07-0.13-0.42-183.31
Operating cash flow per share
00.07-0.46-0.76-12.58
Free cash flow per share
00.04-0.6-0.84-16.5
Cash per share
00.060.930.4617.58
Book value per share
00.089.846.8816.48
Tangible book value per share
0-0.15-0.37-2.27-52.75
Share holders equity per share
00.089.846.8816.48
Interest debt per share
00.362.374.26120.51
Market cap
037.56B11.83B9.85B55.73M
Enterprise value
-4.44M37.58B11.9B10.18B482.14M
P/E ratio
06.32K-1.77K-260.71-0.08
Price to sales ratio
0363.144015.610.07
POCF ratio
07.06K-495.9-144.45-1.19
PFCF ratio
011.87K-385-130.23-0.91
P/B Ratio
05.58K23.4115.910.91
PTB ratio
05.58K23.4115.910.91
EV to sales
-0.05363.3540.2316.120.64
Enterprise value over EBITDA
-0.593.36K-340.96-1.51K-7.56
EV to operating cash flow
-0.637.07K-498.81-149.17-10.28
EV to free cash flow
-0.7111.87K-387.25-134.48-7.84
Earnings yield
0000-12.26
Free cash flow yield
000-0.01-1.1
Debt to equity
3.114.060.230.596.43
Debt to assets
0.660.710.180.310.63
Net debt to EBITDA
-0.592-1.99-47.75-6.69
Current ratio
3.022.734.922.550.42
Interest coverage
05.84-6.08-1.43-1.89
Income quality
1.170.73.571.80.07
Dividend Yield
00000
Payout ratio
0.720.62000
Sales general and administrative to revenue
0.130.070.140.120.11
Research and developement to revenue
00000
Intangibles to total assets
0.440.480.80.70.41
Capex to operating cash flow
-0.1-0.40.290.110.31
Capex to revenue
-0.01-0.02-0.02-0.01-0.02
Capex to depreciation
-0.75-1.43-0.52-0.34-0.37
Stock based compensation to revenue
0000.020.01
Graham number
00.375.378.07260.74
ROIC
0.320.22-0.04-0.02-0.19
Return on tangible assets
0.440.3-0.05-0.11-1.87
Graham Net
0-0.24-1.32-4.4-110.06
Working capital
6.72M9.43M86.09M120.01M-255.46M
Tangible asset value
-5.67M-11.92M-19.01M-204.68M-196.64M
Net current asset value
-9.32M-16.9M-39.68M-353.86M-378.51M
Invested capital
3.114.060.230.596.43
Average receivables
07.43M25.83M96.52M132.9M
Average payables
01.28M2.08M5.4M6.98M
Average inventory
012.81K282.5K636.5K361.5K
Days sales outstanding
20.934.1251.8387.3555.77
Days payables outstanding
10.714.574.295.0911.89
Days of inventory on hand
0.080.070.760.480
Receivables turnover
17.4710.77.044.186.55
Payables turnover
34.0779.9184.9971.6630.7
Inventory turnover
4.86K5.56K480.57761.87192.66M
ROE
1.170.88-0.01-0.06-11.12
Capex per share
0-0.03-0.13-0.08-3.92

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.631.562.011.840.59
Net income per share
0.1-0.74-0.29-0.92-124.53
Operating cash flow per share
-0.28-0.2-0.19-0.174.15
Free cash flow per share
-0.31-0.22-0.22-0.22.39
Cash per share
0.410.40.490.2917.52
Book value per share
6.144.875.594.6816.43
Tangible book value per share
-2.03-1.63-0.81-0.94-52.57
Share holders equity per share
6.144.875.594.6816.43
Interest debt per share
3.693.724.194.01109.97
Market cap
11.05B8.88B10.42B7.13B55.92M
Enterprise value
11.37B9.24B10.82B7.56B482.32M
P/E ratio
264.69-27.06-80.43-17.28-0.03
Price to sales ratio
67.2551.3646.4135.320.37
POCF ratio
-388.91-408.57-484.09-371.613.6
PFCF ratio
-356.44-369.71-425.76-324.686.26
P/B Ratio
17.8316.4616.6813.590.91
PTB ratio
17.8316.4616.6813.590.91
EV to sales
69.2153.4348.1937.463.18
Enterprise value over EBITDA
7.45K-2.26K1.14K-68.44-6.73
EV to operating cash flow
-400.24-425.06-502.7-394.131.06
EV to free cash flow
-366.82-384.62-442.13-344.3354.03
Earnings yield
0-0.010-0.01-8.33
Free cash flow yield
00000.16
Debt to equity
0.590.750.730.886.43
Debt to assets
0.310.370.40.440.63
Net debt to EBITDA
210.8-87.5742.12-3.91-5.95
Current ratio
2.552.612.231.80.42
Interest coverage
-0.66-1.01-0.288.38-4.96
Income quality
-2.720.260.660.19-0.03
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.10.140.090.10.11
Research and developement to revenue
00000
Intangibles to total assets
0.70.660.620.590.41
Capex to operating cash flow
0.090.110.140.14-0.43
Capex to revenue
-0.02-0.01-0.01-0.01-0.04
Capex to depreciation
-0.36-0.35-0.23-0.28-0.65
Stock based compensation to revenue
0.020.010.010.020.02
Graham number
3.7896.049.84214.54
ROIC
0.01-0.010-0.11-0.15
Return on tangible assets
0.03-0.22-0.07-0.24-1.28
Graham Net
-3.92-3.56-3.15-3.53-109.69
Working capital
120.01M129.57M120.58M78.32M-255.46M
Tangible asset value
-204.68M-181.07M-90.68M-104.92M-196.64M
Net current asset value
-353.86M-347.94M-307.82M-356.84M-378.51M
Invested capital
0.590.750.730.886.43
Average receivables
118.4M155.01M159.4M150.2M127.67M
Average payables
10.55M7.91M8.41M9.01M7.81M
Average inventory
817K361.5K0.50.51
Days sales outstanding
82.7582.7264.0862.6868.02
Days payables outstanding
4.844.93.964.611.35
Days of inventory on hand
0.460000
Receivables turnover
1.091.091.41.441.32
Payables turnover
18.5818.3622.7319.587.93
Inventory turnover
197.51149.3M0182.97M49.78M
ROE
0.02-0.15-0.05-0.2-7.58
Capex per share
-0.03-0.02-0.03-0.02-1.77

CMAX Frequently Asked Questions

What is CareMax, Inc. stock symbol ?

CareMax, Inc. is a US stock , located in Miami of Fl and trading under the symbol CMAX

Is CareMax, Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $6. The lowest prediction is $6 and the highest is $6

What is CMAX stock prediction ?

What is CareMax, Inc. stock quote today ?

CareMax, Inc. stock price is $4.82 today.

Is CareMax, Inc. stock public?

Yes, CareMax, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap